Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,682 | -17,800 |
| Depreciation Amortization | 241 | 1,040 |
| Accounts receivable | -28 | N/A |
| Accounts payable and accrued liabilities | 40 | N/A |
| Other Working Capital | -5,840 | -13,710 |
| Other Operating Activity | 147 | 570 |
| Operating Cash Flow | $-11,122 | $-29,900 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -49 | -1,030 |
| Sale Of Investment | 245 | N/A |
| Other Investing Activity | 0 | -470 |
| Investing Cash Flow | $196 | $-1,500 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 16 | N/A |
| Other Financing Activity | 0 | 37,900 |
| Financing Cash Flow | $16 | $37,900 |
| Exchange Rate Effect | -3 | -3 |
| Beginning Cash Position | 53,753 | 47,260 |
| End Cash Position | 42,840 | 53,750 |
| Net Cash Flow | $-10,913 | $6,490 |
| Free Cash Flow | ||
| Operating Cash Flow | -11,122 | -29,900 |
| Capital Expenditure | -49 | N/A |
| Free Cash Flow | -11,171 | -29,900 |